Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Froeling

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.
Nature Genetics|February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Nature Genetics|January 15, 2020
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Cell Reports|May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerHolly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.
Nature Genetics|February 14, 2020
Author Correction: Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Nature Genetics|January 15, 2020
Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolutionMichelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, et al.
Cell Reports|May 14, 2020
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerHolly Brunton, Giuseppina Caligiuri, Richard Cunningham, et al.
Gastroenterology|October 11, 2020
Targeting DNA Damage Response and Replication Stress in Pancreatic CancerStephan B Dreyer, Rosie Upstill-Goddard, Viola Paulus-Hock, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Pageof 6